Don’t be disappointed too much, we have a great HC PYC community here to keep you/each other informed as best we can.
Lot’s to learn, still a humble student, as shareholders we have a ticket that seats us somewhere in the midsection of the genomic medicine theatre… let’s see how the plot unfolds this year, its being written behind the lab curtain, and we’re not shy of some drama
We had a big run-up to the intro, and are now halfway down from the climax, but the cliff hanger awaits!
Ann: Quarterly Activities and Appendix 4C Cash Flow Report, page-18
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.010(5.56%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $537.4K | 3.013M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 240589 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 76524 | 2 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |